Evidence map›Paper›PMID 7530982›Full record

ArticleBritish journal of cancer1995

Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line.

H Shiozaki, T Kadowaki, Y Doki, M Inoue, S Tamura, H Oka, T Iwazawa, S Matsui, K Shimaya, M Takeichi

Open access · bronzeAbstract read
In one paragraph

Article in British journal of cancer, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 137 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The role of adhesion molecules in gastric ulcer healing.World journal of gastroenterology · 1998
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

H ShiozakiDepartment of Surgery II, Osaka University Medical School, Japan.
T Kadowaki
Y Doki
M Inoue
S Tamura
H Oka
T Iwazawa
S Matsui
K Shimaya
M Takeichi
Osaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidermal growth factor (EGF) mediates many pleiotrophic biological effects, one of which is alteration of cellular morphology. In the present study, we examine the possibility that this alteration in cell morphology is caused in part by the dysfunction of cadherin-mediated cell-cell adhesion using the human oesophageal cancer cell line TE-2R, which expresses E-cadherin and EGF receptor. In the presence of EGF, TE-2R changed its shape from round to fibroblastic and its colony formation from compact to sparse. Vanadate, a tyrosine phosphatase inhibitor, further potentiated the EGF response, whereas herbimycin A, a tyrosine kinase inhibitor, interfered with it. Moreover, EGF enabled the cells to invade in organotypic raft culture. These phenomena were accompanied not by decreased expression of the E-cadherin molecule but by a change in its localisation from the lateral adhesion site to the whole cell surface. Both alpha- and beta-catenin, cadherin-binding proteins, were also expressed at the same level throughout these morphological changes. Finally, we examined tyrosine phosphorylation of E-cadherin and alpha- and beta-catenin, and observed tyrosine phosphorylation of beta-catenin induced by EGF. These results suggest that EGF counteracts E-cadherin-mediated junctional assembly through phosphorylation of beta-catenin and modulates tumour cell behaviour to a more aggressive phenotype.

Indexed as

Trans-Activatorsalpha CateninBenzoquinonesbeta CateninCadherinsCarcinoma, Squamous CellCell AdhesionCell AggregationCell LineCulture TechniquesCytoskeletal ProteinsEpidermal Growth FactorErbB ReceptorsEsophageal NeoplasmsFibroblastsFluorescent Antibody Techniquealpha CateninBenzoquinonesbeta CateninCadherinsCTNNA1 protein, humanCTNNB1 protein, humanCytoskeletal ProteinsEpidermal Growth FactorErbB ReceptorsGelsherbimycinLactams, MacrocyclicNeoplasm ProteinsPhosphotyrosineQuinonesRifabutinTrans-ActivatorsTyrosineVanadates

Identifiers

PMID7530982
PMCPMC2033604
OpenAlexW2002695314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.